Blacksmith Medicines Announces Publication in Journal of Medicinal Chemistry Highlighting Discovery of a Non-Hydroxamate LpxC Inhibitor

Non-hydroxamate LpxC InhibitorPositive

AI Analysis

Summary

Blacksmith Medicines announced publication of research in the Journal of Medicinal Chemistry regarding the discovery of a non-hydroxamate LpxC inhibitor for metalloenzyme-targeting therapeutics.

Importance:2/10

Sentiment:

0.30

publicationresearchdiscoveryLpxC inhibitormetalloenzymes

Related Companies

$INTI $CBDY

Read the original article

Published by PR Newswire Clinical Trials on August 5, 2026 2:00 PM

Read Original